SBRA - Sabra Health Care REIT, Inc.
NASDAQ
->
Real Estate
->
REIT—Healthcare Facilities
Irvine,
United States
Type: Equity
SBRA price evolution
SBRA
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $46.72 | $38.86 | $32.38 | $38.68 |
| Short term investments | ||||
| Net receivables | $133.81 | $152.24 | $146.64 | $132.74 |
| Inventory | ||||
| Total current assets | $175.09 | $185.5 | $173.88 | $166.27 |
| Long term investments | ||||
| Property, plant & equipment | $4617.26 | $4603.01 | $4751.9 | $4797.04 |
| Goodwill & intangible assets | $30.9 | $32.75 | $35.99 | $39.37 |
| Total noncurrent assets | ||||
| Total investments | $557.47 | $553.7 | $557.42 | $548.48 |
| Total assets | $5386.15 | $5380.56 | $5524.33 | $5556.31 |
| Current liabilities | ||||
| Accounts payable | $136.98 | $128.04 | $121.86 | $143 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $136.98 | $128.04 | $121.87 | $143 |
| Long term debt | $2414.1 | $2349.48 | $2420.04 | $2396.62 |
| Total noncurrent liabilities | ||||
| Total debt | $2414.1 | $2349.48 | $2420.04 | $2396.62 |
| Total liabilities | $2583.62 | $2511.71 | $2580.59 | $2580.08 |
| Shareholders' equity | ||||
| Retained earnings | -$1718.28 | -$1665.05 | -$1579.91 | -$1531.23 |
| Other shareholder equity | $23.75 | $39.67 | $32.24 | $17.44 |
| Total shareholder equity | $2802.53 | $2868.85 | $2943.74 | $2976.23 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $46.72 | $53.93 | $115.89 | $65.52 |
| Short term investments | ||||
| Net receivables | $133.81 | $147.91 | $138.11 | $160.65 |
| Inventory | ||||
| Total current assets | $175.09 | $197.22 | $250.1 | $219.7 |
| Long term investments | ||||
| Property, plant & equipment | $4617.26 | $4959.34 | $5162.88 | $5285.04 |
| Goodwill & intangible assets | $30.9 | $40.13 | $54.06 | $82.8 |
| Total noncurrent assets | ||||
| Total investments | $557.47 | $546.36 | $495.77 | $391.6 |
| Total assets | $5386.15 | $5747.67 | $5966.71 | $5985.6 |
| Current liabilities | ||||
| Accounts payable | $136.98 | $124.06 | $142.99 | $146.28 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $136.98 | $142.26 | $142.99 | $146.3 |
| Long term debt | $2414.1 | $2506.77 | $2394.47 | $2372.4 |
| Total noncurrent liabilities | ||||
| Total debt | $2414.1 | $2506.77 | $2394.47 | $2372.37 |
| Total liabilities | $2583.62 | $2691.28 | $2587.18 | $2576.38 |
| Shareholders' equity | ||||
| Retained earnings | -$1718.28 | -$1451.94 | -$1095.2 | -$716.2 |
| Other shareholder equity | $23.75 | $19.06 | -$10.02 | -$39.91 |
| Total shareholder equity | $2802.53 | $3056.39 | $3379.53 | $3409.23 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $163.4 | $161.63 | $161.17 | $161.32 |
| Cost of revenue | ||||
| Gross Profit | $163.4 | $161.63 | $161.17 | $161.32 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $16.68 | $10.76 | $9.53 | $10.5 |
| Total operating expenses | $116.34 | $103.16 | $102.84 | $117.99 |
| Operating income | $47.05 | $58.47 | $58.33 | $43.33 |
| Income from continuing operations | ||||
| EBIT | $45.59 | $13.51 | $49.84 | $19.78 |
| Income tax expense | $0.49 | $0.46 | $0.33 | $0.73 |
| Interest expense | $27.94 | $28.16 | $28.33 | $28.54 |
| Net income | ||||
| Net income | $17.16 | -$15.1 | $21.19 | -$9.49 |
| Income (for common shares) | $17.16 | -$15.1 | $21.19 | -$9.49 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $647.51 | $624.81 | $569.54 | $598.57 |
| Cost of revenue | ||||
| Gross Profit | $647.51 | $624.81 | $569.54 | $598.57 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $47.47 | $39.57 | $34.67 | $32.76 |
| Total operating expenses | $440.33 | $484.15 | $368.3 | $346.9 |
| Operating income | $207.19 | $140.66 | $201.25 | $251.67 |
| Income from continuing operations | ||||
| EBIT | $128.72 | $29.11 | -$12.78 | $239.55 |
| Income tax expense | $2 | $1.24 | $1.84 | $0.71 |
| Interest expense | $112.96 | $105.47 | $98.63 | $100.42 |
| Net income | ||||
| Net income | $13.76 | -$77.61 | -$113.26 | $138.42 |
| Income (for common shares) | $13.76 | -$77.61 | -$113.26 | $138.42 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $17.16 | -$15.1 | $21.19 | -$9.49 |
| Operating activities | ||||
| Depreciation | $42.88 | $43.24 | $44.14 | $52.83 |
| Business acquisitions & disposals | -$0.44 | -$4.8 | ||
| Stock-based compensation | $2.45 | $2.23 | $1 | $2.23 |
| Total cash flows from operations | $78.74 | $83.22 | $70.33 | $68.29 |
| Investing activities | ||||
| Capital expenditures | -$60.56 | $53.52 | -$1.81 | $93.09 |
| Investments | -$0.58 | $0.41 | -$6.93 | $24.88 |
| Total cash flows from investing | -$61.78 | $59.93 | -$8.19 | $113.17 |
| Financing activities | ||||
| Dividends paid | -$69.37 | -$69.37 | -$69.36 | -$69.35 |
| Sale and purchase of stock | -$0.49 | -$0.04 | -$0.31 | -$1.85 |
| Net borrowings | $60.49 | -$66.98 | $19.09 | -$124.87 |
| Total cash flows from financing | -$9.36 | -$136.39 | -$68.47 | -$196.07 |
| Effect of exchange rate | $0.27 | -$0.27 | $0.03 | -$0.64 |
| Change in cash and equivalents | $7.59 | $6.75 | -$6.34 | -$14.61 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $13.76 | -$77.61 | -$113.26 | $138.42 |
| Operating activities | ||||
| Depreciation | $183.09 | $187.78 | $178.99 | $176.74 |
| Business acquisitions & disposals | -$5.24 | -$142.91 | $1.3 | |
| Stock-based compensation | $7.92 | $7.45 | $7.91 | $7.91 |
| Total cash flows from operations | $300.57 | $315.73 | $356.39 | $354.85 |
| Investing activities | ||||
| Capital expenditures | $84.24 | -$51.37 | -$41.38 | -$140.3 |
| Investments | $17.78 | -$21.96 | -$294.82 | -$14.21 |
| Total cash flows from investing | $103.13 | -$216.25 | -$336.2 | -$136.45 |
| Financing activities | ||||
| Dividends paid | -$277.45 | -$277.16 | -$262.92 | -$278.3 |
| Sale and purchase of stock | -$2.68 | -$4.81 | $308.71 | $80.09 |
| Net borrowings | -$112.27 | $122.76 | -$15.65 | -$3.9 |
| Total cash flows from financing | -$410.3 | -$161.71 | $30.14 | -$202.11 |
| Effect of exchange rate | -$0.61 | $0.27 | $0.03 | $0.09 |
| Change in cash and equivalents | -$6.6 | -$62.22 | $50.33 | $16.29 |
News
Fundamentals
| Market cap | $3.16B |
|---|---|
| Enterprise value | $5.52B |
| Shares outstanding | 231.27M |
| Revenue | $647.51M |
|---|---|
| EBITDA | $311.81M |
| EBIT | $128.72M |
| Net Income | $13.76M |
| Revenue Q/Q | -0.96% |
| Revenue Y/Y | 3.63% |
| P/E ratio | 229.48 |
|---|---|
| EV/Sales | 8.53 |
| EV/EBITDA | 17.72 |
| EV/EBIT | 42.92 |
| P/S ratio | 4.88 |
| P/B ratio | 1.14 |
| Book/Share | 12.02 |
| Cash/Share | 0.20 |
| EPS | $0.06 |
|---|---|
| ROA | 0.25% |
| ROE | 0.47% |
| Debt/Equity | 0.92 |
|---|---|
| Net debt/EBITDA | 8.14 |
| Current ratio | 1.28 |
| Quick ratio | 1.28 |